How does amiodarone (Cordarone) interact with warfarin and what dose adjustments and INR monitoring are required?

Warfarin-Amiodarone Interaction: Dosing and Monitoring

When amiodarone (Cordarone) is initiated in a patient taking warfarin, reduce the warfarin dose by 30–50% immediately and monitor INR at least weekly for the first 6 weeks, as this drug interaction potentiates anticoagulation and peaks at approximately 7 weeks. 1, 2

Mechanism of Interaction

Amiodarone is a potent inhibitor of CYP2C9, the primary enzyme responsible for warfarin metabolism, leading to reduced warfarin clearance and sudden, pronounced increases in prothrombin time and INR. 1 The interaction is primarily mediated by desethylamiodarone (DEA), amiodarone's active metabolite, which strongly inhibits CYP2C9. 3 This explains why the effect is delayed and prolonged—amiodarone has an exceptionally long half-life averaging 58 days (range 15–100 days), and DEA accumulates gradually. 1

Magnitude and Timing of the Interaction

• Peak effect occurs at 7 weeks after amiodarone initiation, though INR elevation begins within the first week. 1, 4
• The warfarin dose requirement decreases by an average of 25–44% depending on the amiodarone maintenance dose. 1, 4, 5
• In a Swedish nationwide cohort of 754 patients, mean INR increased from 2.6 to 3.1, and 37% of patients developed supratherapeutic INR >3.0 within 3 weeks of starting amiodarone. 5
• The interaction magnitude is dose-dependent: patients on amiodarone 400 mg/day require approximately 40% warfarin dose reduction, while those on 100 mg/day require only 25% reduction. 4

Warfarin Dose Adjustment Algorithm

Initial dose reduction (when starting amiodarone):

• Reduce warfarin dose by one-third to one-half (33–50%) immediately upon amiodarone initiation. 1, 2
• The FDA label specifies this reduction should occur at the start of concomitant therapy. 2

Maintenance dose adjustment based on amiodarone dose: 4

• Amiodarone 400 mg/day → reduce warfarin by ~40%
• Amiodarone 300 mg/day → reduce warfarin by ~35%
• Amiodarone 200 mg/day → reduce warfarin by ~30%
• Amiodarone 100 mg/day → reduce warfarin by ~25%

INR Monitoring Protocol

Intensive monitoring phase (first 6 weeks):

• Monitor INR at least weekly during the first 6 weeks of concomitant therapy. 1, 6
• In clinical practice, 67% of patients had INR checked within 1 week and 90% within 2 weeks of amiodarone initiation. 5
• Continue frequent monitoring until INR stabilizes within therapeutic range (typically 2.0–3.0). 1

Extended monitoring:

• Because peak interaction effects occur at 7 weeks, vigilant INR surveillance should continue through at least week 7. 1, 6
• After stabilization, monitor INR every 1–2 months if stability is maintained. 1

Special Considerations and Risk Factors

Renal function significantly modifies interaction magnitude:

• In patients with normal renal function (CrCl 115 mL/min), amiodarone increases warfarin sensitivity by 36% and raises supratherapeutic INR risk substantially (HR 1.80). 7
• In patients with severe renal dysfunction (CrCl 15 mL/min), the interaction is attenuated—warfarin sensitivity increases only 11.8% with negligible effect on supratherapeutic INR risk (HR 1.01). 7
• This threefold variation across the renal function spectrum suggests patients with preserved renal function require more aggressive warfarin dose reduction and closer monitoring. 7

Simultaneous initiation of both drugs:

• When warfarin and amiodarone are started simultaneously (rather than adding amiodarone to stable warfarin), an enhanced pharmacodynamic response occurs early in therapy. 8
• More patients initiated on both drugs concurrently had INR >2 during the first 5 days compared to warfarin alone, despite lower total warfarin doses. 8
• This scenario requires particularly cautious dosing and monitoring from the outset. 8

Bleeding Risk and Safety

• Minor bleeding episodes occurred in 12% of patients in one cohort study. 4
• The proportion of patients with INR >4.0 increased from 0.9% to 5.5% after amiodarone initiation. 5
• To minimize bleeding risk, anticipate an average 25% warfarin dose reduction and implement weekly INR monitoring for at least 6 weeks. 5

Common Pitfalls to Avoid

• Do not wait for INR elevation before reducing warfarin dose—the dose reduction should be preemptive at amiodarone initiation. 1, 2
• Do not assume the interaction has fully manifested at 2–3 weeks—peak effects occur at 7 weeks, requiring sustained vigilance. 1
• Do not use standard warfarin dosing algorithms that do not account for amiodarone co-administration, as they will underestimate the interaction. 4
• Do not overlook renal function—patients with normal kidney function experience a much stronger interaction and require more aggressive management. 7

Postoperative Context

In patients with postoperative atrial fibrillation after cardiac surgery, the bleeding risk associated with anticoagulation must be carefully weighed against stroke risk. 1 When amiodarone is used in this setting, a 25–40% warfarin dose reduction is required depending on amiodarone dose. 1 If AF persists >48 hours, anticoagulation with warfarin (target INR 2.0–3.0) is recommended, but warfarin may be started without heparin bridging due to enhanced postoperative bleeding risk. 1